Global Regulatory Requirements for Bioequivalence Studies
About Course
Welcome to Global Regulatory Requirements for Bioequivalence Studies. Whether you are a regulatory affairs specialist, a clinical researcher, a formulation scientist, or a biostatistician, you are stepping into one of the most dynamic, high-stakes sectors of modern pharmaceutical development.
In the pharmaceutical industry, bringing a generic drug to market isn’t about discovering a new molecule, it is about proving absolute therapeutic equivalence. At the heart of approving these products lies the concept of bioequivalence (BE).
But designing and executing a successful BE study is a high-stakes balancing act. A single flaw in your pharmacokinetic (PK) sampling schedule, a misunderstanding of statistical power, or a failure to align with evolving FDA, EMA, or ICH guidelines can result in a rejected application, costing companies millions of dollars and months of delay.
This course is your comprehensive, industry-aligned blueprint for navigating this complex landscape. By compiling global regulatory requirements, it provides a clear framework to confidently build your BE strategy.
Who Should Enroll:
- Formulation scientists
- Regulatory affairs professionals
- Biostatistician
- Anyone interested in bioequivalence study
Course Format:
- Self-paced online modules
- Lifetime access
- Quizzes & certification upon completion
Course Content
Module I
-
Key Concepts of Bioequivalence Studies
-
Study Design for Pharmacokinetic Endpoint
-
Fasting and Fed Study Conditions
-
Considerations for the Bioequivalence Analysis Population
-
M13A: Bioequivalence for Immediate-Release Solid Oral Dosage Forms
01:57:15 -
Pre Assessment-1
Module II
Module III
Module IV
Final Assessment
Earn a certificate
Add this certificate to your resume to demonstrate your skills & increase your chances of getting noticed.
It will be helpful for regulatory market product development.